Protective effect of scFv-DAF fusion protein on the complement attack to acetylcholine receptor: a possible option for treatment of myasthenia gravis.
about
Improved methodology to obtain large quantities of correctly folded recombinant N-terminal extracellular domain of the human muscle acetylcholine receptor for inducing experimental autoimmune myasthenia gravis in rats.Targeting therapy to the neuromuscular junction: proof of concept.The role of complement in experimental autoimmune myasthenia gravis.
P2860
Protective effect of scFv-DAF fusion protein on the complement attack to acetylcholine receptor: a possible option for treatment of myasthenia gravis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Protective effect of scFv-DAF ...... reatment of myasthenia gravis.
@ast
Protective effect of scFv-DAF ...... reatment of myasthenia gravis.
@en
type
label
Protective effect of scFv-DAF ...... reatment of myasthenia gravis.
@ast
Protective effect of scFv-DAF ...... reatment of myasthenia gravis.
@en
prefLabel
Protective effect of scFv-DAF ...... reatment of myasthenia gravis.
@ast
Protective effect of scFv-DAF ...... reatment of myasthenia gravis.
@en
P2093
P2860
P356
P1433
P1476
Protective effect of scFv-DAF ...... reatment of myasthenia gravis.
@en
P2093
Fanglin Zhang
Henry J Kaminski
Jianting Miao
P2860
P304
P356
10.1002/MUS.23247
P577
2012-05-01T00:00:00Z